Chromadex (NASDAQ:CDXC) and Aurora Cannabis (NYSE:ACB) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Institutional Insider Ownership
17.2% of Chromadex shares are owned by institutional investors. Comparatively, 0.1% of Aurora Cannabis shares are owned by institutional investors. 10.3% of Chromadex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Chromadex and Aurora Cannabis’ net margins, return on equity and return on assets.
Valuation and Earnings
This table compares Chromadex and Aurora Cannabis’ gross revenue, earnings per share (EPS) and valuation.
Aurora Cannabis has